A detailed history of Iam Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Iam Advisory, LLC holds 1,523 shares of ABBV stock, worth $261,544. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,523
Previous 1,511 0.79%
Holding current value
$261,544
Previous $259,000 15.83%
% of portfolio
0.08%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $1,966 - $2,391
12 Added 0.79%
1,523 $300,000
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $2,321 - $2,711
-15 Reduced 0.98%
1,511 $259,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $6,073 - $6,919
38 Added 2.55%
1,526 $277,000
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $412 - $464
3 Added 0.2%
1,488 $230,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $198,381 - $229,655
1,485 New
1,485 $221,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Iam Advisory, LLC Portfolio

Follow Iam Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iam Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iam Advisory, LLC with notifications on news.